Strength
10 g/10g
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00310111039
Classification
Brand
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
SODIUM ZIRCONIUM CYCLOSILICATEApproval Type
New Drug (NDA)
FDA Application
NDA207078On Market Since
9/4/2018
Related Drugs
Same classification
No related drugs found.